- Home
- XCUR vs HHS Comparison
XCUR vs HHS Comparison
Compare XCUR & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- HHS
- Stock Information
- Founded
- XCUR 2011
- HHS 1923
- Country
- XCUR United States
- HHS United States
- Employees
- XCUR N/A
- HHS N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- XCUR Health Care
- HHS Consumer Discretionary
- Exchange
- XCUR Nasdaq
- HHS Nasdaq
- Market Cap
- XCUR 74.1M
- HHS 37.0M
- IPO Year
- XCUR N/A
- HHS N/A
- Fundamental
- Price
- XCUR $11.38
- HHS $4.45
- Analyst Decision
- XCUR
- HHS
- Analyst Count
- XCUR 0
- HHS 0
- Target Price
- XCUR N/A
- HHS N/A
- AVG Volume (30 Days)
- XCUR 31.6K
- HHS 20.1K
- Earning Date
- XCUR 06-16-2025
- HHS 05-16-2025
- Dividend Yield
- XCUR N/A
- HHS N/A
- EPS Growth
- XCUR N/A
- HHS N/A
- EPS
- XCUR N/A
- HHS N/A
- Revenue
- XCUR $500,000.00
- HHS $185,242,000.00
- Revenue This Year
- XCUR N/A
- HHS $6.54
- Revenue Next Year
- XCUR N/A
- HHS N/A
- P/E Ratio
- XCUR N/A
- HHS N/A
- Revenue Growth
- XCUR N/A
- HHS N/A
- 52 Week Low
- XCUR $1.44
- HHS $4.27
- 52 Week High
- XCUR $36.00
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- XCUR 51.56
- HHS 44.29
- Support Level
- XCUR $9.81
- HHS $4.77
- Resistance Level
- XCUR $11.58
- HHS $4.81
- Average True Range (ATR)
- XCUR 1.00
- HHS 0.34
- MACD
- XCUR 0.02
- HHS -0.01
- Stochastic Oscillator
- XCUR 58.32
- HHS 14.63
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.